Maria Jesus Moran Plata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Maria Jesus Moran Plata has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Luca Salassa
Euskal Herriko Unibertsitatea UPV/EHU, Paseo Manuel de Lardizabal 3, Donostia, Spain, 20018
5 shared publications - Alessio Terenzi
Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche, Università degli Studi di Palermo, Viale delle Scienze, Edificio 17, Palermo, Italy, 90128
3 shared publications - Fernando López-Gallego
Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo Miramon 194, 20014 San Sebastián, Spain
3 shared publications - Nadia Barbero
Department of Chemistry, NIS Interdepartmental Centre and INSTM, University of Turin, Via Gioacchino Quarello 15/a, Turin 10135, Italy
3 shared publications - Ana Cristina Carrasco
Euskal Herriko Unibertsitatea UPV/EHU, Paseo Manuel de Lardizabal 3, Donostia, Spain, 20018
2 shared publications Beatrice Bernadette Mascitti
Euskal Herriko Unibertsitatea UPV/EHU, Paseo Manuel de Lardizabal 3, Donostia, Spain, 20018
2 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1489
Group 8 Bimetallic Complexes for Light-Driven Cancer Therapy
The incorporation of a second metal center with different biological targets and complementary physicochemical properties into metal-based compounds represents a promising strategy to enhance anticancer efficacy and overcome the limitations of conventional monometallic drugs. In recent years, increasing attention has been devoted to multitarget anticancer agents, including heterometallic complexes. This review provides an overview of recent advances in Group 8 bimetallic complexes containing iron, ruthenium, or osmium for light-driven cancer therapy. Particular emphasis is placed on their molecular design, photophysical and photochemical properties, mechanisms of action, and anticancer activity. The influence of the two metal centers on photoactivation, generation of reactive species, cellular targets, and therapeutic efficacy is discussed, together with emerging structure–activity relationships. Finally, current challenges and future perspectives for the development of these complexes as photoactivated anticancer agents are highlighted.
- 18 November 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (11) , 1489
Open AccessGroup 8 Bimetallic Complexes for Light-Driven Cancer Therapy
The incorporation of a second metal center with different biological targets and complementary physicochemical properties into metal-based compounds represents a promising strategy to enhance anticancer efficacy and overcome the limitations of conventional monometallic drugs. In recent years, increasing attention has been devoted to multitarget anticancer agents, including heterometallic complexes. This review provides an overview of recent advances in Group 8 bimetallic complexes containing iron, ruthenium, or osmium for light-driven cancer therapy. Particular emphasis is placed on their molecular design, photophysical and photochemical properties, mechanisms of action, and anticancer activity. The influence of the two metal centers on photoactivation, generation of reactive species, cellular targets, and therapeutic efficacy is discussed, together with emerging structure–activity relationships. Finally, current challenges and future perspectives for the development of these complexes as photoactivated anticancer agents are highlighted.
- Open Access
- 9 November 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Pt(II)-Flavin Complexes As Anticancer And Antibacterial Agents
We report a new chelating pyridyl–imine ligand bearing a riboflavin-derived pendant group and its Pt(II) complexes 1 and 2, designed as cisplatin- and oxaliplatin-like derivatives. Both complexes reacted with DNA and a histone-derived peptide, with 1 showing markedly higher covalent reactivity. However, this trend was not reflected in biological activity. Complex 2 displayed micromolar antiproliferative effects and pronounced antibacterial activity, particularly against Bacillus subtilis, whereas 1 was inactive in the tested models. Cellular accumulation studies excluded enhanced Pt uptake as the origin of this difference. Fluorescence microscopy performed on Escherichia Coli and Bacillus subtilis indicated that 2 affects bacterial DNA and membrane potential, consistent with a dual antibacterial mechanism. Comparison with oxaliplatin and the free flavin ligands showed that both the Pt–oxalate fragment and the riboflavin-containing ligand are required for activity.
- 9 November 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessPt(II)-Flavin Complexes As Anticancer And Antibacterial Agents
We report a new chelating pyridyl–imine ligand bearing a riboflavin-derived pendant group and its Pt(II) complexes 1 and 2, designed as cisplatin- and oxaliplatin-like derivatives. Both complexes reacted with DNA and a histone-derived peptide, with 1 showing markedly higher covalent reactivity. However, this trend was not reflected in biological activity. Complex 2 displayed micromolar antiproliferative effects and pronounced antibacterial activity, particularly against Bacillus subtilis, whereas 1 was inactive in the tested models. Cellular accumulation studies excluded enhanced Pt uptake as the origin of this difference. Fluorescence microscopy performed on Escherichia Coli and Bacillus subtilis indicated that 2 affects bacterial DNA and membrane potential, consistent with a dual antibacterial mechanism. Comparison with oxaliplatin and the free flavin ligands showed that both the Pt–oxalate fragment and the riboflavin-containing ligand are required for activity.
- Open Access
- 23 September 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Pt(II)-Flavin Complexes As Anticancer And Antibacterial Agents
We report a new chelating pyridyl–imine ligand bearing a riboflavin-derived pendant group and its Pt(II) complexes 1 and 2, designed as cisplatin- and oxaliplatin-like derivatives. Both complexes reacted with DNA and a histone-derived peptide, with 1 showing markedly higher covalent reactivity. However, this trend was not reflected in biological activity. Complex 2 displayed micromolar antiproliferative effects and pronounced antibacterial activity, particularly against Bacillus subtilis, whereas 1 was inactive in the tested models. Cellular accumulation studies excluded enhanced Pt uptake as the origin of this difference. Fluorescence microscopy performed on Escherichia Coli and Bacillus subtilis indicated that 2 affects bacterial DNA and membrane potential, consistent with a dual antibacterial mechanism. Comparison with oxaliplatin and the free flavin ligands showed that both the Pt–oxalate fragment and the riboflavin-containing ligand are required for activity.
- 23 September 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessPt(II)-Flavin Complexes As Anticancer And Antibacterial Agents
We report a new chelating pyridyl–imine ligand bearing a riboflavin-derived pendant group and its Pt(II) complexes 1 and 2, designed as cisplatin- and oxaliplatin-like derivatives. Both complexes reacted with DNA and a histone-derived peptide, with 1 showing markedly higher covalent reactivity. However, this trend was not reflected in biological activity. Complex 2 displayed micromolar antiproliferative effects and pronounced antibacterial activity, particularly against Bacillus subtilis, whereas 1 was inactive in the tested models. Cellular accumulation studies excluded enhanced Pt uptake as the origin of this difference. Fluorescence microscopy performed on Escherichia Coli and Bacillus subtilis indicated that 2 affects bacterial DNA and membrane potential, consistent with a dual antibacterial mechanism. Comparison with oxaliplatin and the free flavin ligands showed that both the Pt–oxalate fragment and the riboflavin-containing ligand are required for activity.
- Open Access
- 4 September 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Rational Design of a Red-Light Absorbing dinuclear Ruthenium (II) Complex with Photodynamic potential
Conventional chemotherapeutic agents often suffer from systemic toxicity, poor selectivity, and the emergence of drug resistance, highlighting the urgent need for alternative anticancer strategies. In this context, light-activated therapies have emerged as promising minimally invasive approaches for controlled cancer treatment. However, the development of single molecular systems capable of integrating multiple photoinduced therapeutic mechanisms remains challenging. Herein, we report the rational design, synthesis, and comprehensive characterization of novel multifunctional bimetallic ruthenium complexes incorporating three photoactive units within a single molecular scaffold. The complexes exhibited favorable photophysical properties, efficient light absorption, and enhanced reactive oxygen species generation upon 690 nm LED irradiation. Computational investigations provided insight into the electronic structure and excited-state behavior, revealing potential photoinduced pathways associated with the multinuclear architecture. In addition, combined electrochemical analyses revealed the formation of Ru-DPP-Ru-DNA supramolecular assemblies, providing evidence of DNA binding while maintaining the electrochemical activity of the Ru(II) centers. ROS generation studies demonstrated a predominant Type II pathway involving singlet oxygen production, together with a minor contribution from Type I ROS. In vitro biological studies demonstrated neglible dark toxicity alongside moderate photocytotoxic activity under red light irradiation. This work presents the first example of DPP ligands scaffolds incorporated in a metal coordination sphere, a promising strategy for the development of next-generation bimetallic complexes as potential multimodal photoresponsive therapeutics for cancer treatment.
- 4 September 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessRational Design of a Red-Light Absorbing dinuclear Ruthenium (II) Complex with Photodynamic potential
Conventional chemotherapeutic agents often suffer from systemic toxicity, poor selectivity, and the emergence of drug resistance, highlighting the urgent need for alternative anticancer strategies. In this context, light-activated therapies have emerged as promising minimally invasive approaches for controlled cancer treatment. However, the development of single molecular systems capable of integrating multiple photoinduced therapeutic mechanisms remains challenging. Herein, we report the rational design, synthesis, and comprehensive characterization of novel multifunctional bimetallic ruthenium complexes incorporating three photoactive units within a single molecular scaffold. The complexes exhibited favorable photophysical properties, efficient light absorption, and enhanced reactive oxygen species generation upon 690 nm LED irradiation. Computational investigations provided insight into the electronic structure and excited-state behavior, revealing potential photoinduced pathways associated with the multinuclear architecture. In addition, combined electrochemical analyses revealed the formation of Ru-DPP-Ru-DNA supramolecular assemblies, providing evidence of DNA binding while maintaining the electrochemical activity of the Ru(II) centers. ROS generation studies demonstrated a predominant Type II pathway involving singlet oxygen production, together with a minor contribution from Type I ROS. In vitro biological studies demonstrated neglible dark toxicity alongside moderate photocytotoxic activity under red light irradiation. This work presents the first example of DPP ligands scaffolds incorporated in a metal coordination sphere, a promising strategy for the development of next-generation bimetallic complexes as potential multimodal photoresponsive therapeutics for cancer treatment.
- Open Access
- 10 July 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Overcoming Flavin-Driven Inactivation of Alcohol Dehydrogenases Through Enzyme Immobilization
Flavins are organocatalyst that can be employed as photocatalyst, but also as cofactor regeneration systems when coupled with alcohol dehydrogenases (ADHs) for alcohol oxidation reactions. In previous work, we developed a confined (organo)enzymatic system where ADH catalyzes NAD⁺-dependent regioselective diol oxidation, while FMN enables ground-state NAD⁺ regeneration using molecular oxygen as the electron acceptor. Despite co-immobilization on the same support, the flavin induces premature ADH inactivation during discontinuous use of the heterogeneous hybrid catalyst. Through experimental and computational methods, we herein investigate how FMN interacts with ADHs triggering their inactivation. We found that the isoalloxazine ring and the ribityl moiety of flavins disrupt ADH’s quaternary structure via nonspecific binding at subunit interfaces, creating an oxidative microenvironment that oxidizes surface-exposed cysteine residues. By immobilizing and compartmentalizing flavins and ADHs through a cationic polymer layer, we enhanced the operational stability of this hybrid heterogenous catalyst, maintaining its maximum oxidative performance for three consecutive reaction cycles, outperforming flavin-dependent oxidation systems previously reported. Collectively, this work shows that microscopic catalyst compartmentalization via rational immobilization overcomes flavin–dehydrogenase incompatibilities in cascade reactions, enabling a robust integration of chemo- and biocatalysts for concurrent reaction routes.
- 10 July 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessOvercoming Flavin-Driven Inactivation of Alcohol Dehydrogenases Through Enzyme Immobilization
Flavins are organocatalyst that can be employed as photocatalyst, but also as cofactor regeneration systems when coupled with alcohol dehydrogenases (ADHs) for alcohol oxidation reactions. In previous work, we developed a confined (organo)enzymatic system where ADH catalyzes NAD⁺-dependent regioselective diol oxidation, while FMN enables ground-state NAD⁺ regeneration using molecular oxygen as the electron acceptor. Despite co-immobilization on the same support, the flavin induces premature ADH inactivation during discontinuous use of the heterogeneous hybrid catalyst. Through experimental and computational methods, we herein investigate how FMN interacts with ADHs triggering their inactivation. We found that the isoalloxazine ring and the ribityl moiety of flavins disrupt ADH’s quaternary structure via nonspecific binding at subunit interfaces, creating an oxidative microenvironment that oxidizes surface-exposed cysteine residues. By immobilizing and compartmentalizing flavins and ADHs through a cationic polymer layer, we enhanced the operational stability of this hybrid heterogenous catalyst, maintaining its maximum oxidative performance for three consecutive reaction cycles, outperforming flavin-dependent oxidation systems previously reported. Collectively, this work shows that microscopic catalyst compartmentalization via rational immobilization overcomes flavin–dehydrogenase incompatibilities in cascade reactions, enabling a robust integration of chemo- and biocatalysts for concurrent reaction routes.
- Open Access
- 17 July 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Alloxazine-Based Ligands And Their Ruthenium Complexes As NADH Oxidation Catalysts And G4 Binders
Flavin-like ligands (L-1 and L-2) with extended π-conjugation were synthesized using microwave-assisted techniques. An N,N-chelating fragment was integrated into alloxazine units, providing binding sites for metal ions while retaining redox activity. The complexation capability of L-1 and L-2 with two prototypical Ru-scaffolds was examined to design Ru(II) complexes (M-1 and M-2), whose electronic properties were studied and compared with their corresponding ligands via absorption and emission spectroscopy, computational analysis (DFT and TD-DFT), and cyclic voltammetry (CV). The ability of L-1 and M-1 to undergo alloxazine/isoalloxazine tautomerization was demonstrated to play a crucial role in the photocatalytic oxidation of NADH, including under green and red wavelengths. Moreover, the interaction of M-1 and M-2 with B-DNA and G-quadruplex structures was investigated. M-2 showed high stabilization of Kit1 and h-Telo oligonucleotides. Meanwhile, M-1 demonstrated switchable emissive properties with B-DNA and induced conformational changes in the h-Telo G-quadruplex structure.
- 17 July 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessAlloxazine-Based Ligands And Their Ruthenium Complexes As NADH Oxidation Catalysts And G4 Binders
Flavin-like ligands (L-1 and L-2) with extended π-conjugation were synthesized using microwave-assisted techniques. An N,N-chelating fragment was integrated into alloxazine units, providing binding sites for metal ions while retaining redox activity. The complexation capability of L-1 and L-2 with two prototypical Ru-scaffolds was examined to design Ru(II) complexes (M-1 and M-2), whose electronic properties were studied and compared with their corresponding ligands via absorption and emission spectroscopy, computational analysis (DFT and TD-DFT), and cyclic voltammetry (CV). The ability of L-1 and M-1 to undergo alloxazine/isoalloxazine tautomerization was demonstrated to play a crucial role in the photocatalytic oxidation of NADH, including under green and red wavelengths. Moreover, the interaction of M-1 and M-2 with B-DNA and G-quadruplex structures was investigated. M-2 showed high stabilization of Kit1 and h-Telo oligonucleotides. Meanwhile, M-1 demonstrated switchable emissive properties with B-DNA and induced conformational changes in the h-Telo G-quadruplex structure.
- Open Access
- 28 June 2023
- Published by Wiley in ChemCatChem
- Vol. 15 (14)
Chemoenzymatic Oxidation of Diols Catalyzed by Co‐Immobilized Flavins and Dehydrogenases**
Enzyme driven oxidations catalyzed by alcohol dehydrogenases rely on the in situ NAD(P)+ regeneration. A wide variety of chemoenzymatic and fully enzymatic methods have been reported over the last 30 years to integrate the cofactor regeneration in biocatalytic oxidations. However, the majority of examples are limited to homogeneous systems where the reuse of both enzymes and chemical catalysts are challenging. In this work, we co‐immobilize an alcohol dehydrogenase from Bacillus stearothermophilus with a flavin derivative (FMN), which performs as an organocatalyst that oxidizes NADH back to NAD+. This latter oxidized cofactor is sequentially utilized by the dehydrogenase to oxidize 1,ω‐diols. Remarkably, the immobilization chemistry of FMN determines its efficiency to oxidize NADH and, unlike in its free state, the immobilized FMN can recycle NAD+ in dark. This is possible because the support where both enzyme and FMN are immobilized also captures NADH, making the electron transfer from the substrates to the cofactors more efficient. This work illustrates how the co‐immobilization and confinement of bio and chemical catalysts on solid materials (heterogeneous phase) enable chemoenzymatic cascades that are precluded in solution (homogeneous phase).
- 28 June 2023
- Published by Wiley in ChemCatChem
- Vol. 15 (14)
Open AccessChemoenzymatic Oxidation of Diols Catalyzed by Co‐Immobilized Flavins and Dehydrogenases**
Enzyme driven oxidations catalyzed by alcohol dehydrogenases rely on the in situ NAD(P)+ regeneration. A wide variety of chemoenzymatic and fully enzymatic methods have been reported over the last 30 years to integrate the cofactor regeneration in biocatalytic oxidations. However, the majority of examples are limited to homogeneous systems where the reuse of both enzymes and chemical catalysts are challenging. In this work, we co‐immobilize an alcohol dehydrogenase from Bacillus stearothermophilus with a flavin derivative (FMN), which performs as an organocatalyst that oxidizes NADH back to NAD+. This latter oxidized cofactor is sequentially utilized by the dehydrogenase to oxidize 1,ω‐diols. Remarkably, the immobilization chemistry of FMN determines its efficiency to oxidize NADH and, unlike in its free state, the immobilized FMN can recycle NAD+ in dark. This is possible because the support where both enzyme and FMN are immobilized also captures NADH, making the electron transfer from the substrates to the cofactors more efficient. This work illustrates how the co‐immobilization and confinement of bio and chemical catalysts on solid materials (heterogeneous phase) enable chemoenzymatic cascades that are precluded in solution (homogeneous phase).
- Open Access
- 10 March 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (3) , 902
Quatsomes Loaded with Squaraine Dye as an Effective Photosensitizer for Photodynamic Therapy
Photodynamic therapy is a non-invasive therapeutic strategy that combines external light with a photosensitizer (PS) to destroy abnormal cells. Despite the great progress in the development of new photosensitizers with improved efficacy, the PS’s photosensitivity, high hydrophobicity, and tumor target avidity still represent the main challenges. Herein, newly synthesized brominated squaraine, exhibiting intense absorption in the red/near-infrared region, has been successfully incorporated into Quatsome (QS) nanovesicles at different loadings. The formulations under study have been characterized and interrogated in vitro for cytotoxicity, cellular uptake, and PDT efficiency in a breast cancer cell line. The nanoencapsulation of brominated squaraine into QS overcomes the non-water solubility limitation of the brominated squaraine without compromising its ability to generate ROS rapidly. In addition, PDT effectiveness is maximized due to the highly localized PS loadings in the QS. This strategy allows using a therapeutic squaraine concentration that is 100 times lower than the concentration of free squaraine usually employed in PDT. Taken together, our results reveal the benefits of the incorporation of brominated squaraine into QS to optimize their photoactive properties and support their applicability as photosensitizer agents for PDT.
- 10 March 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (3) , 902
Open AccessQuatsomes Loaded with Squaraine Dye as an Effective Photosensitizer for Photodynamic Therapy
Photodynamic therapy is a non-invasive therapeutic strategy that combines external light with a photosensitizer (PS) to destroy abnormal cells. Despite the great progress in the development of new photosensitizers with improved efficacy, the PS’s photosensitivity, high hydrophobicity, and tumor target avidity still represent the main challenges. Herein, newly synthesized brominated squaraine, exhibiting intense absorption in the red/near-infrared region, has been successfully incorporated into Quatsome (QS) nanovesicles at different loadings. The formulations under study have been characterized and interrogated in vitro for cytotoxicity, cellular uptake, and PDT efficiency in a breast cancer cell line. The nanoencapsulation of brominated squaraine into QS overcomes the non-water solubility limitation of the brominated squaraine without compromising its ability to generate ROS rapidly. In addition, PDT effectiveness is maximized due to the highly localized PS loadings in the QS. This strategy allows using a therapeutic squaraine concentration that is 100 times lower than the concentration of free squaraine usually employed in PDT. Taken together, our results reveal the benefits of the incorporation of brominated squaraine into QS to optimize their photoactive properties and support their applicability as photosensitizer agents for PDT.
- Open Access
- 30 January 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Chemoenzymatic oxidation of diols catalyzed by co-immobilized flavins and dehydrogenases
Enzyme driven oxidations catalyzed by alcohol dehydrogenases rely on the in situ NAD(P)+ regeneration. A wide variety of chemoenzymatic and fully enzymatic methods have been reported over the last 30 years to integrate the cofactor regeneration in biocatalytic oxidations. However, the most examples are limited to homogeneous systems where the reuse of both enzymes and chemical catalysts are challenging. In this work, we co-immobilized an alcohol dehydrogenase from Bacillus stearothermophilus with a flavin derivative (FMN), which performs as an organocatalyst that oxidizes NADH back to NAD+. This latter oxidized cofactor is sequentially utilized by the dehydrogenase to oxidize 1,-diols. Remarkably, the immobilization chemistry of the FMN determines its efficiency to recycle the nicotinamide cofactor and, unlike in its free state, the immobilized FMN can oxidizes NADH in dark. This was possible because the support where both enzyme and FMN are immobilized also captures NADH, and makes the electron transfer from the substrates to the cofactors more efficient. This work illustrates how the co-immobilization and confinement of bio and chemical catalysts on solid materials (heterogeneous system) enable chemoenzymatic cascades that are precluded in solution (homogeneous system).
- 30 January 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessChemoenzymatic oxidation of diols catalyzed by co-immobilized flavins and dehydrogenases
Enzyme driven oxidations catalyzed by alcohol dehydrogenases rely on the in situ NAD(P)+ regeneration. A wide variety of chemoenzymatic and fully enzymatic methods have been reported over the last 30 years to integrate the cofactor regeneration in biocatalytic oxidations. However, the most examples are limited to homogeneous systems where the reuse of both enzymes and chemical catalysts are challenging. In this work, we co-immobilized an alcohol dehydrogenase from Bacillus stearothermophilus with a flavin derivative (FMN), which performs as an organocatalyst that oxidizes NADH back to NAD+. This latter oxidized cofactor is sequentially utilized by the dehydrogenase to oxidize 1,-diols. Remarkably, the immobilization chemistry of the FMN determines its efficiency to recycle the nicotinamide cofactor and, unlike in its free state, the immobilized FMN can oxidizes NADH in dark. This was possible because the support where both enzyme and FMN are immobilized also captures NADH, and makes the electron transfer from the substrates to the cofactors more efficient. This work illustrates how the co-immobilization and confinement of bio and chemical catalysts on solid materials (heterogeneous system) enable chemoenzymatic cascades that are precluded in solution (homogeneous system).
- 22 November 2022
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2022 (44)
Unconventional and Sustainable Synthesis of Polymethine Dyes: Critical Overview and Perspectives within the Framework of the Twelve Principles of Green Chemistry
Time, energy, and cost saving; waste reduction; health and safety preservation represent true milestones of green chemistry, as well as some of the most important aspects for the industrial synthesis of molecules having relevant technological applications. Herein, in the light of the non‐conventional and sustainable approaches towards polymethine dyes that appeared in the literature in the last decade, the twelve principles of green chemistry serve as a guideline for a critical overview of such protocols. The E factor and the EcoScale score for the considered procedures are also assessed, to provide numerical parameters for the evaluation of their impact.
- 22 November 2022
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2022 (44)
Unconventional and Sustainable Synthesis of Polymethine Dyes: Critical Overview and Perspectives within the Framework of the Twelve Principles of Green Chemistry
Time, energy, and cost saving; waste reduction; health and safety preservation represent true milestones of green chemistry, as well as some of the most important aspects for the industrial synthesis of molecules having relevant technological applications. Herein, in the light of the non‐conventional and sustainable approaches towards polymethine dyes that appeared in the literature in the last decade, the twelve principles of green chemistry serve as a guideline for a critical overview of such protocols. The E factor and the EcoScale score for the considered procedures are also assessed, to provide numerical parameters for the evaluation of their impact.